Citations (59)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Alberto Verrotti, Giulia Iapadre, Giulia Di Donato, Ludovica Di Francesco, Luca Zagaroli, Sara Matricardi, Vincenzo Belcastro & Maria Laura Iezzi. (2019) Pharmacokinetic considerations for anti-epileptic drugs in children. Expert Opinion on Drug Metabolism & Toxicology 15:3, pages 199-211.
Read now
Read now
Alessandra Morano, Luigi Iannone, Caterina Palleria, Martina Fanella, Anna Teresa Giallonardo, Giovambattista De Sarro, Emilio Russo & Carlo Di Bonaventura. (2019) Pharmacology of new and developing intravenous therapies for the management of seizures and epilepsy. Expert Opinion on Pharmacotherapy 20:1, pages 25-39.
Read now
Read now
Bader Alyahya, Marjorie Friesen, Bénédicte Nauche & Martin Laliberté. (2018) Acute lamotrigine overdose: a systematic review of published adult and pediatric cases. Clinical Toxicology 56:2, pages 81-89.
Read now
Read now
P. W. Moore, J. W. Donovan, K. K. Burkhart & D. Haggerty. (2013) A case series of patients with lamotrigine toxicity at one center from 2003 to 2012. Clinical Toxicology 51:7, pages 545-549.
Read now
Read now
Articles from other publishers (55)
Isidro Badillo-Ramírez, Selina A. J. Janssen, Gohar Soufi, Roman Slipets, Kinga Zór & Anja Boisen. (2023) Label-free SERS assay combined with multivariate spectral data analysis for lamotrigine quantification in human serum. Microchimica Acta 190:12.
Crossref
Crossref
Lucia Bernasconi, Azzurra Schicchi, Valeria M. Petrolini, Alberto Malovini, Davide Lonati, Federico Fassio, Eleonora Buscaglia, Giulia Scaravaggi, Francesca Crema & Carlo A. Locatelli. (2023) Clinical characteristics of acute lacosamide poisoning: Pavia Poison Control Centre experience. British Journal of Clinical Pharmacology.
Crossref
Crossref
Nada Božina, Ivana Šušak Sporiš, Iva Klarica Domjanović, Lana Ganoci, Livija Šimičević, Mila Lovrić, Zrinka Čolak Romić, Željka Petelin Gadže & Vladimir Trkulja. (2023) Bearing variant alleles at uridine glucuronosyltransferase polymorphisms UGT2B7 -161C > T (rs7668258) or UGT1A4*3 c.142 T > G (rs2011425) has no relevant consequences for lamotrigine troughs in adults with epilepsy. European Journal of Clinical Pharmacology 79:8, pages 1117-1129.
Crossref
Crossref
Bárbara Costa & Nuno Vale. (2023) Understanding Lamotrigine’s Role in the CNS and Possible Future Evolution. International Journal of Molecular Sciences 24:7, pages 6050.
Crossref
Crossref
Kamil Kośmider, Maciej Kamieniak, Stanisław J. Czuczwar & Barbara Miziak. (2023) Second Generation of Antiepileptic Drugs and Oxidative Stress. International Journal of Molecular Sciences 24:4, pages 3873.
Crossref
Crossref
Yiqian Chen, Jingzhen Chen, Xiaorong Zhuang, Xingyu Chen, Jianqi Zeng, Ru Wang & Jiayin Miao. (2022) Risk factors of elevated blood ammonia level in epilepsy patients treated with lamotrigine. Medicine 101:26, pages e29780.
Crossref
Crossref
Kelly E. Wood, Kendra L. Palmer & Matthew D. Krasowski. (2021) Data on the relationship between lamotrigine and levetiracetam serum/plasma levels and toxicity: Experience at an academic medical center. Data in Brief 39, pages 107555.
Crossref
Crossref
Alicia MastroccoAlex L. BlutingerSamantha A. BaineJennifer E. Prittie. (2021) Use of injectable lipid emulsion and sodium bicarbonate to treat severe cardiovascular collapse secondary to lamotrigine toxicosis in a dog. Journal of the American Veterinary Medical Association 258:5, pages 510-514.
Crossref
Crossref
Frank M.C. Besag, Michael J. Vasey, Aditya N. Sharma & Ivan C.H. Lam. (2021) Efficacy and safety of lamotrigine in the treatment of bipolar disorder across the lifespan: a systematic review. Therapeutic Advances in Psychopharmacology 11, pages 204512532110458.
Crossref
Crossref
Kelly E. Wood, Kendra L. Palmer & Matthew D. Krasowski. (2021) Correlation of elevated lamotrigine and levetiracetam serum/plasma levels with toxicity: A long-term retrospective review at an academic medical center. Toxicology Reports 8, pages 1592-1598.
Crossref
Crossref
Karina Sommerfeld-Klatta, Barbara Zielińska-Psuja, Marta Karaźniewcz-Łada & Franciszek K. Główka. (2020) New Methods Used in Pharmacokinetics and Therapeutic Monitoring of the First and Newer Generations of Antiepileptic Drugs (AEDs). Molecules 25:21, pages 5083.
Crossref
Crossref
Janthima Methaneethorn & Nattawut Leelakanok. (2020) Sources of lamotrigine pharmacokinetic variability: A systematic review of population pharmacokinetic analyses. Seizure 82, pages 133-147.
Crossref
Crossref
Patsy Ramey, Melissa Osborn, Howard Kirshner & Bassel Abou-Khalil. (2020) Misdiagnosis of lamotrigine toxicity as posterior circulation transient ischemic attack or stroke. Epilepsy & Behavior 111, pages 107284.
Crossref
Crossref
Cinthya Eloisa Chávez-Castillo, Susanna Edith Medellín-Garibay, Rosa del Carmen Milán-Segovia, Ildefonso Rodríguez-Leyva & Silvia Romano-Moreno. (2020) Dosing Recommendations Based on Population Pharmacokinetics of Lamotrigine in Mexican Adult Patients With Epilepsy. Journal of Pharmaceutical Sciences 109:9, pages 2902-2908.
Crossref
Crossref
Amitava Dasgupta & Matthew D. Krasowski. 2020. Therapeutic Drug Monitoring Data. Therapeutic Drug Monitoring Data
99
158
.
Abhinav Agrawal, Joshua N. Nogar & Seth Koenig. (2019) Management of lamotrigine overdose using hemodialysis. The American Journal of Emergency Medicine 37:8, pages 1603.e1-1603.e2.
Crossref
Crossref
Puja K. Gangurde, Navya Ajitkumar B.Lalit Kumar. (2018) Lamotrigine Lipid Nanoparticles for Effective Treatment of Epilepsy: a Focus on Brain Targeting via Nasal Route. Journal of Pharmaceutical Innovation 14:2, pages 91-111.
Crossref
Crossref
Shansen Xu, Limin Liu, Yanan Chen, Mei Liu, Tong Lu, Huanxin Wang, Shihao Liu, Mingming Zhao & Limei Zhao. (2018) Population pharmacokinetics of lamotrigine co-administered with valproic acid in Chinese epileptic children using nonlinear mixed effects modeling. European Journal of Clinical Pharmacology 74:5, pages 583-591.
Crossref
Crossref
T. Yu. Noskova, D. A. Abaimov, A. K. Sariev, P. A. Fedin, A. V. Krasnikov, V. V. Shvedkov & R. D. Sejfulla. (2018) The clinical significance of the lamotrigine pharmacokinetic variability. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 118:1, pages 23.
Crossref
Crossref
EM Tunbridge, MJ Attenburrow, A Gardiner, JM Rendell, C Hinds, GM Goodwin, PJ Harrison & JR Geddes. (2017) Biochemical and genetic predictors and correlates of response to lamotrigine and folic acid in bipolar depression: Analysis of the CEQUEL clinical trial. Bipolar Disorders 19:6, pages 477-486.
Crossref
Crossref
Gali Pariente, Tom Leibson, Talya Shulman, Thomasin Adams-Webber, Eran Barzilay & Irena Nulman. (2017) Pregnancy Outcomes Following In Utero Exposure to Lamotrigine: A Systematic Review and Meta-Analysis. CNS Drugs 31:6, pages 439-450.
Crossref
Crossref
P. Ramey, M. R. Osborn, K. M. Lowen, R. C. Reed & B. Abou-Khalil. (2017) Unexplained spikes in lamotrigine serum concentration: nonlinear elimination?. Acta Neurologica Scandinavica 135:2, pages 240-246.
Crossref
Crossref
Akiyoshi Kikkawa, Yoshihisa Kitamura, Tetsuya Aiba, Koichi Hiraki & Toshiaki Sendo. (2017) Correlation between the Efficacy of Lamotrigine and the Serum Lamotrigine Level during the Remission Phase of Acute Bipolar II Depression: A Naturalistic and Unblinded Prospective Pilot Study. Biological & Pharmaceutical Bulletin Biological and Pharmaceutical Bulletin 40:4, pages 413-418.
Crossref
Crossref
Akintunde Alabi, Adam Todd, Andrew Husband & Joe Reilly. (2016) Safety profile of lamotrigine in overdose. Therapeutic Advances in Psychopharmacology 6:6, pages 369-381.
Crossref
Crossref
Shery Jacob & Anroop B. Nair. (2016) An Updated Overview on Therapeutic Drug Monitoring of Recent Antiepileptic Drugs. Drugs in R&D 16:4, pages 303-316.
Crossref
Crossref
Sandra Gastrup, Tore Bjerregaard Stage, Palle Bach Nielsen Fruekilde & Per Damkier. (2016) Paracetamol decreases steady-state exposure to lamotrigine by induction of glucuronidation in healthy subjects. British Journal of Clinical Pharmacology 81:4, pages 735-741.
Crossref
Crossref
Gwendolyn A. McMillin & Matthew D. Krasowski. 2016. Clinical Challenges in Therapeutic Drug Monitoring. Clinical Challenges in Therapeutic Drug Monitoring
101
134
.
Edoardo Spina & Domenico Italiano. 2016. Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents. Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents
177
203
.
James Jackson, Betsy McCollum, Amy O’Neill & Jose de Leon. (2015) A Case Report That Suggested That the Patient Was Very Sensitive to Induction and Needed 1600 mg/d of Lamotrigine to Get Therapeutic Concentrations. Journal of Clinical Psychopharmacology 35:6, pages 745-747.
Crossref
Crossref
Limin Liu, Limei Zhao, Qiuning Wang, Feng Qiu, Xiujun Wu & Yanan Ma. (2015) Influence of valproic acid concentration and polymorphism of UGT1A4*3, UGT2B7 -161C > T and UGT2B7*2 on serum concentration of lamotrigine in Chinese epileptic children. European Journal of Clinical Pharmacology 71:11, pages 1341-1347.
Crossref
Crossref
O. Freudenreich. (2015) Clozapine‐induced myocarditis: prescribe safely but do prescribe. Acta Psychiatrica Scandinavica 132:4, pages 240-241.
Crossref
Crossref
Ana Serralheiro, Gilberto Alves, Ana Fortuna & Amílcar Falcão. (2015) Direct nose-to-brain delivery of lamotrigine following intranasal administration to mice. International Journal of Pharmaceutics 490:1-2, pages 39-46.
Crossref
Crossref
Daniela Milosheska, Iztok Grabnar & Tomaž Vovk. (2015) Dried blood spots for monitoring and individualization of antiepileptic drug treatment. European Journal of Pharmaceutical Sciences 75, pages 25-39.
Crossref
Crossref
Jose de Leon. (2015) The effects of antiepileptic inducers in neuropsychopharmacology, a neglected issue. Part I: A summary of the current state for clinicians. Revista de Psiquiatría y Salud Mental (English Edition) 8:2, pages 97-115.
Crossref
Crossref
Jose de Leon. (2015) Efectos de los inductores antiepil?pticos en la neuropsicofarmacolog?a: una cuesti?n ignorada. Parte I: Resumen para los cl?nicos de la situaci?n actual. Revista de Psiquiatr?a y Salud Mental 8:2, pages 97-115.
Crossref
Crossref
M P Burnham, P M Sharpe, C Garner, R Hughes, C E Pollard & J Bowes. (2014) Investigation of connexin 43 uncoupling and prolongation of the cardiac QRS complex in preclinical and marketed drugs. British Journal of Pharmacology 171:21, pages 4808-4819.
Crossref
Crossref
Matthew D. Krasowski & Gwendolyn A. McMillin. (2014) Advances in anti-epileptic drug testing. Clinica Chimica Acta 436, pages 224-236.
Crossref
Crossref
Thomas J. Bateman, Vijay G.B. Reddy, Masakazu Kakuni, Yoshio Morikawa & Sanjeev Kumar. (2014) Application of Chimeric Mice with Humanized Liver for Study of Human-Specific Drug Metabolism. Drug Metabolism and Disposition 42:6, pages 1055-1065.
Crossref
Crossref
Philip N. Patsalos & Dave J. Berry. (2013) Therapeutic Drug Monitoring of Antiepileptic Drugs by Use of Saliva. Therapeutic Drug Monitoring 35:1, pages 4-29.
Crossref
Crossref
Da-ke He, Li Wang, Jiong Qin, Shen Zhang, Wei Lu, Ling Li, Jian-ming Zhang, Wei-qun Bao, Xiao-qing Song & Hai-tao Liu. (2012) Population pharmacokinetics of lamotrigine in Chinese children with epilepsy. Acta Pharmacologica Sinica 33:11, pages 1417-1423.
Crossref
Crossref
S. Magnolon, L. Raidelet, P. Munier, K. Barrial, T. Le Bricon & J. Bronner. (2012) Performances et stabilité du réactif QMS® lamotrigine sur CDx90® (ThermoFisherScientific). Immuno-analyse & Biologie Spécialisée 27:3, pages 117-121.
Crossref
Crossref
Dave Berry. 2012. Neurology and Pregnancy. Neurology and Pregnancy
27
33
.
Kevin Beattie, Geeta Phadke & Jasmina Novakovic. 2012.
245
285
.
Jose de Leon. 2012. A Practitioner's Guide to Prescribing Antiepileptics and Mood Stabilizers for Adults with Intellectual Disabilities. A Practitioner's Guide to Prescribing Antiepileptics and Mood Stabilizers for Adults with Intellectual Disabilities
155
184
.
Jose de Leon. 2012. A Practitioner's Guide to Prescribing Antiepileptics and Mood Stabilizers for Adults with Intellectual Disabilities. A Practitioner's Guide to Prescribing Antiepileptics and Mood Stabilizers for Adults with Intellectual Disabilities
419
460
.
Jonathan Bullman, Andrew Nicholls, Kevan Van Landingham, Richard Fleck, Alain Vuong, James Miller, Sarah Alexander & John Messenheimer. (2011) Effects of lamotrigine and phenytoin on the pharmacokinetics of atorvastatin in healthy volunteers. Epilepsia 52:7, pages 1351-1358.
Crossref
Crossref
Matthew D. Krasowski. (2010) Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications. Pharmaceuticals 3:6, pages 1909-1935.
Crossref
Crossref
Sophie Dupont, Marc Verny, Sandrine Harston, Leslie Cartz-Piver, Stéphane Schück, Jennifer Martin, François Puisieux, Cosmin Alecu, Hervé Vespignani, Cécile Marchal & Philippe Derambure. (2010) Seizures in the elderly: Development and validation of a diagnostic algorithm. Epilepsy Research 89:2-3, pages 339-348.
Crossref
Crossref
L. Almeida, T. Nunes, E. Sicard, J.-F. Rocha, A. Falcão, J.-S. Brunet, M. Lefebvre & P. Soares-da-Silva. (2010) Pharmacokinetic interaction study between eslicarbazepine acetate and lamotrigine in healthy subjects. Acta Neurologica Scandinavica 121:4, pages 257-264.
Crossref
Crossref
Danièle Bentué-Ferrer, Olivier Tribut & Marie-Clémence Verdier. (2010) Suivi thérapeutique pharmacologique de la lamotrigine. Therapies 65:1, pages 39-46.
Crossref
Crossref
S. Dupont, M. Verny, S. Harston, L. Cartz-Piver, F. Puisieux, A. Benetos, H. Vespignani, C. Marchal & P. Derambure. (2009) Spécificités des crises d’épilepsie chez le sujet âgé : proposition d’un score électro-radioclinique d’orientation. Revue Neurologique 165:10, pages 803-811.
Crossref
Crossref
Nuria Rivas, Dolores Santos Buelga, Christian E Elger, José Santos-Borbujo, María José Otero, Alfonso Domínguez-Gil & María José García. (2008) Population Pharmacokinetics of Lamotrigine with Data from Therapeutic Drug Monitoring in German and Spanish Patients with Epilepsy. Therapeutic Drug Monitoring 30:4, pages 483-489.
Crossref
Crossref
Philip N. Patsalos, David J. Berry, Blaise F. D. Bourgeois, James C. Cloyd, Tracy A. Glauser, Svein I. Johannessen, Ilo E. Leppik, Torbjrn Tomson & Emilio Perucca. (2008) Antiepileptic drugsbest practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia 49:7, pages 1239-1276.
Crossref
Crossref
A. D. Wickenden, J. L. Krajewski, B. London, P. K. Wagoner, W. A. Wilson, S. Clark, R. Roeloffs, G. McNaughton-Smith & G. C. Rigdon. (2008)
N
-(6-Chloro-pyridin-3-yl)-3,4-difluoro-benzamide (ICA-27243): A Novel, Selective KCNQ2/Q3 Potassium Channel Activator
. Molecular Pharmacology 73:3, pages 977-986.
Crossref
Crossref
Pasquale Striano, Salvatore Striano, Carlo Minetti & Federico Zara. (2008) Refractory, life-threatening status epilepticus in a 3-year-old girl. The Lancet Neurology 7:3, pages 278-284.
Crossref
Crossref